Medtronic has announced a partnership with a Chinese municipal government to expand access to diabetes treatments.
Medtronic plans on investing in a manufacturing facility in Chengdu, China, to develop a pump system with its SmartGuard technology. The company will also work with the municipal government in Chengdu to make the technology available to people with diabetes in the Sichuan province. The software will be displayed in Chinese, according to Medtronic.
In September 2015, Medtronic first announced a strategic partnership agreement with the city of Chengdu, in which both parties agreed to expand access to diabetes medications and other proven therapies.
In addition, Medtronic announced in August 2014 that it would open a factory for portable hemodialysis equipment in Chengdu.
Executive Editor
Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.